California Pumping $19 Million More into Stem Cell Effort to Improve Kidney Transplant Success
The California stem cell agency is set to make a nearly $19 million bet next week on a treatment that is aimed at significantly improving the success of kidney transplants and helping to reduce healthcare costs.
The agency's board is expected to ratify a decision to award $18.8 million to Medeor Therapeutics, Inc., of San Mateo, Ca., for a phase 3 clin…
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.